SIGNAL PHARMACEUTICALS, INC.
Patent Owner
Stats
- 9 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 17, 2009 most recent publication
Details
- 9 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 387 Total Citation Count
- Apr 14, 1992 Earliest Filing
- 35 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6258579 Stimulus-inducible protein kinase complex and methods of use thereforAug 13, 97Jul 10, 01[C12N]
6150372 Pyridopyrimidine analogs and related compounds and methods for treating inflammatory conditionsJun 28, 99Nov 21, 00[A61K, C07D]
5972674 Stimulus-inducible protein kinase complex and methods of use thereforAug 26, 96Oct 26, 99[C12N]
5939421 Quinazoline analogs and related compounds and methods for treating inflammatory conditionsJul 01, 97Aug 17, 99[A01N, C07D]
5932425 Compositions and methods for modulating cellular NF-.kappa.B activationFeb 18, 97Aug 03, 99[A61K, A01N, C12Q, G01N]
5811428 Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditionsDec 18, 95Sep 22, 98[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
7358056 Methods for modulating signal transduction mediated by TGF-.beta. and related proteinsExpiredAug 30, 99Apr 15, 08[G01N]
7202049 Mitogen-activated protein kinase p38-2 and methods of use thereforExpiredJul 16, 02Apr 10, 07[C12Q]
2006/0110,799 Mitogen-activated protein kinase kinase MEK6 and methods of use thereofAbandonedJan 05, 06May 25, 06[C07H, C12P, C12N]
2005/0255,094 Mitogen-activated protein kinase kinase MEK6 and methods of use thereforAbandonedDec 03, 04Nov 17, 05[A61K, C07H, C12P, C12N]
6913925 Human mesencephalon cell lines and methods of use thereforExpiredAug 12, 98Jul 05, 05[C12P, C12N]
2005/0124,007 Human mesencephalon cell lines and methods of use thereforAbandonedNov 05, 04Jun 09, 05[C12N, G01N]
2005/0064,462 Methods, compositions, and kits for predicting the effect of compounds on hot flash symptomsAbandonedJun 16, 04Mar 24, 05[A61K, C12Q, G01N]
6686351 Compounds and methods for modulation of estrogen receptorsExpiredFeb 27, 02Feb 03, 04[A61K, C07D]
6677130 Mitogen-activated protein kinase p38-2 and methods of use thereforExpiredNov 28, 00Jan 13, 04[A01N, C12N]
6656713 Compounds and methods for modulating activation of NF-.kappa.BExpiredApr 09, 01Dec 02, 03[C12N, C07K]
2003/0175,928 Mitogen-activated protein kinase MEK6 and methods of use thereforAbandonedApr 02, 03Sep 18, 03[C07H, C12P, C12N]
6620838 Benzopyrazone compounds, compositions thereof, and methods of treatment therewithExpiredApr 19, 02Sep 16, 03[A61K, C07D]
6593322 Compounds and methods for modulation of estrogen receptorsExpiredSep 21, 00Jul 15, 03[A61K, C07D]
2003/0119,072 Methods for modulating signal transduction mediated by TGF-beta related proteinsAbandonedDec 02, 02Jun 26, 03[A61K, G01N]
6576437 Stimulus-inducible protein kinase complex and methods of use thereforExpiredApr 27, 01Jun 10, 03[C12Q, C12P, C12N]
2003/0054,528 Mitogen-activated protein kinase p38-2 and methods of use thereforAbandonedJul 18, 02Mar 20, 03[C07H, C12P, C12N]
6521601 Method and composition for inhibition of viral replicationExpiredApr 14, 92Feb 18, 03[A61K, A01N]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.